Navigation Links
Pregis Announces Third Quarter 2008 Financial Results
Date:11/13/2008

(12,764) 972 (17,774) 10,714

Income tax expense (benefit) (802) 1,535 3,029 8,204

Net income (loss) $(11,962) $(563) $(20,803) $2,510

Pregis Holding II Corporation

Consolidated Statements of Cash Flows

Unaudited

(dollars in thousands)

Nine Months Ended September 30,

2008 2007

Operating activities

Net income (loss) $(20,803) $2,510

Adjustments to reconcile net income

(loss) to cash provided by operating

activities:

Depreciation and amortization 40,734 40,736

Deferred income taxes (1,419) 713

Unrealized foreign exchange loss

(gain) 6,814 (3,254)

Amortization of deferred financing

costs 1,781 1,636

Loss (gain) on disposal of property,

plant and equipment (246) (51)

Stock compensation expense 678 334

Impairment of interest rate swap asset 1,299 -

Gain on insurance settlement - (884)

Changes in operating assets and

liabilities, net of effects of

acquisitions:

Accounts and other receivables, net (12,024) (14,384)

Due from Pactiv 6,630 9,202

Inventories, net (9,738) (14,249)

Prepayments and other current assets (143) 1,381

Accounts payable 7,568 15,336

<
'/>"/>
SOURCE Pregis Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Pregis Announces Investor Conference Call to Review 2008 Third Quarter Financial Results
2. Pregis Announces Second Quarter 2008 Financial Results
3. Pregis Announces First Quarter 2008 Financial Results
4. Pregis Announces Fouth Quarter and Full Year 2007 Financial Results
5. Pregis Announces Investor Conference Call to Review 2007 Fourth Quarter and Full Year Financial Results
6. Pregis Corporation Appoints New President of Protective Packaging North America
7. eDiets.com(R) Announces Q3 2008 Results
8. Pharmos Corporation Announces Receipt of Nasdaq Noncompliance Letter
9. Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
10. Debiopharm Announces U.S. NDA Filing of Trelstar(R) 6-Month Formulation for Locally Advanced or Metastatic Prostate Cancer
11. In a Down Economy, Womens Health Company Announces Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... 13, 2014 Fuel additives are chemicals, ... diesel, jet fuel, kerosene, and so on, in order ... for reducing the corrosion effects caused by fuels and ... to any fuel, provide economies of scale in the ... the overall cost of the fuel products. , The ...
(Date:7/13/2014)... 13, 2014 According to a ... Computing Market by Component (processor, GPU, DSP, connectivity), ... Medical), and Geography - Forecast and Analysis to ... Processing & Computing Market is expected to reach ... of 20.75% from 2014 to 2020. , Browse ...
(Date:7/13/2014)... MarketsandMarkets recently conducted a study ... Scanning; 3D rendering; Layout and Animation; Image Reconstruction]: ... 2018)”, which analyzes and studies the major market ... Europe, Eastern Europe, Middle East and Africa, Asia-Pacific ... competitive landscape of the 3D imaging market, providing ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 A Massachusetts ... to the cancer risks associated with power morcellators ( ... their story to federal regulators, as they presented poignant ... Food & Drug Administration (FDA) advisory panel meeting convened ... According to the Rochester Democrat and Chronicle, Dr. Hooman ...
(Date:7/13/2014)... HealthDay Reporter FRIDAY, July 11, ... for people with diabetes is being developed to measure sugar ... report. Scientists at Brown University in Providence, R.I., created ... uses light, metal and a special enzyme that changes color ... have to prick their fingers to draw blood to check ...
Breaking Medicine News(10 mins):Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 2Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 3Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 4Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3
... lung cancer (NSCLC), the most common form of lung ... a small group of patients can also be helped ... published in BioMed Central,s open access journal BMC ... factor receptor (EGFR) using RNAi, alongside TKI (or antibody ...
... kind, a consortium of investigators from 13 countries led the ... the Catholic University of Leuven, Belgium in Europe, found that ... likelihood of leaving also had patients who were more satisfied ... The study was released today in the current issue of ...
... HealthDay Reporter , TUESDAY, March 20 (HealthDay News) -- ... epinephrine -- adrenaline -- might do more harm than ... of hundreds of thousands of cases. Japanese researchers ... likely to survive one month, compared with those who ...
... such as kidney failure and endocrine tumors are among ... the common pain relievers in your medicine cabinet be ... Tel Aviv University,s Sackler Faculty of Medicine and the ... are underlying causes of hypertension, which is a major ...
... , TUESDAY, March 20 (HealthDay News) -- Insects ... Chagas disease are well-established and feeding on human blood in ... What remains a mystery, however, is why the insects ... a serious condition that can lead to life-threatening digestive and ...
... , TUESDAY, March 20 (HealthDay News) -- The ... of altitude sickness, according to a new study. ... among the symptoms of altitude sickness, which affects more ... elevations each year to ski, hike or camp. ...
Cached Medicine News:Health News:Double whammy: RNAi enhances lung cancer therapy 2Health News:International research finds quality and safety problems in hospitals throughout 13 countries 2Health News:Adrenaline Therapy for Cardiac Arrest Linked to Worse Outcomes 2Health News:Adrenaline Therapy for Cardiac Arrest Linked to Worse Outcomes 3Health News:Pain relievers could be spiking your blood pressure 2Health News:Insects Behind Chagas Disease Are Feeding on Humans in the U.S. 2Health News:Ibuprofen May Ward Off Altitude Sickness 2
(Date:7/10/2014)...  Major advances in radiation therapy and radiosurgery ... in a three-day Oncology Summit taking place in ...  Renowned national and international cancer experts from seven countries ... knowledge on modern technologies making treatment for cancer ... The Summit will address a wide spectrum ...
(Date:7/10/2014)... -- RESMED INC. (NYSE: RMD ) today announced that ... June 30, 2014 results on Thursday, July 31, 2014, after ... with ResMed,s results will be issued after 1:00 p.m. US ... discuss operating results and future outlook. The earnings ... Time and the live webcast of the call can be ...
(Date:7/10/2014)... 2014  Decision Resources Group finds that while ... specialists are willing to prescribe Durata,s Dalvance (dalbavancin) ... as OPAT, approximately two-thirds of the respondents reported ... hospital inpatients. However, our findings indicate that nearly ... on OPAT following hospital discharge, and most are ...
Breaking Medicine Technology:Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... , , SILVER SPRING, Md. , Feb. ... approved Xiaflex (collagenase clostridium histolyticum) as the first drug to ... can affect a person,s ability to straighten and properly use ... affects the connective tissue found beneath the skin in the ...
... 2 Vermillion, Inc. (Pink Sheets: VRML) today announced the reappointment ... Company and Eric T. Fung , MD, PhD as Senior Vice ... announced appointment of William C. Wallen , PhD to the Board ... Chair of the Board of Directors. , "Both Dr. Fung and I ...
Cached Medicine Technology:FDA Approves Xiaflex for Debilitating Hand Condition 2Vermillion Announces the Reappointment of Officers and Confirmation of Director 2Vermillion Announces the Reappointment of Officers and Confirmation of Director 3Vermillion Announces the Reappointment of Officers and Confirmation of Director 4
Intermittent catheter...
Intermittent catheter...
Intermittent catheter...
... The new Finnpipette Focus from Thermo Labsystems ... uncompromising performance. Advanced features such as ... fine volume adjustment on microvolumes help to ... single channel pipettes. The new interchangeable handle ...
Medicine Products: